Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2001 Mar;92(3):249–256. doi: 10.1111/j.1349-7006.2001.tb01089.x

Sex Hormone Dependency of Diethylnitrosamine‐induced Liver Tumors in Mice and Chemoprevention by Leuprorelin

Tamaki Nakatani 1,2, Goutam Roy 1, Nariaki Fujimoto 1, Toshimasa Asahara 2, Akihiro Ito 1,✉
PMCID: PMC5926710  PMID: 11267934

Abstract

The prevalence of liver tumors throughout the world makes it imperative to seek chemopreventive agents. This tumor appears to be hormone‐responsive and hormonal manipulations may therefore be beneficial. On this basis, both sexes of 12‐day‐old B6C3FJ mice were injected i.p. with diethylnitrosamine (DEN) at the dose of 2.5 μg/g body weight and observed for 32 weeks (males) or 36 weeks (females). In 100% of male mice, liver tumors were observed with an average diameter of 2.72 mm and multiplicity of 60.8. Orchidectomy at 6 weeks of age in these mice inhibited the incidence, multiplicity and size to 63%, 5.6 and 1.54 mm, respectively. By further implantation with an E2 pellet at monthly intervals, these parameters were reduced to 26%, 0.6 and 0.61 mm, respectively. Administration of a gonadotropin‐blocking chemical, leuprorelin, to DEN‐treated male mice significantly reduced the multiplicity and size of tumors to 18.3 and 2.54 mm (P<0.01 compared to those of DEN only). In female mice, the incidence of liver tumor was significantly smaller than that of males. However, ovariectomy and/or testosterone supplement significantly increased the occurrence of liver tumor. An anti‐estrogen, toremifene, caused a marked further decrease of liver tumors. Mitotic indices with bromodeoxyuridine in tumor tissues paralleled the occurrence of liver tumors. Serum testosterone levels were significantly reduced by orchidectomy or by leuprorelin administration. These results further confirm that liver tumor is testosterone‐responsive and hormonal manipulation by surgical orchidectomy or by chemical orchidectomy i.e. by leuprorelin, could substantially prevent the appearance of liver tumors.

Keywords: Liver tumor, Testosterone, Leuprorelin, DEN, Mice

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

References

  • 1.Chien‐jen , C. , Ming‐whei , Y. . and Yun‐fan , L.Epidemic‐logical characteristics and risk factors of hepatocellular carcinoma . J. Gastroenterol. Hepatol , 12 , S294 – S308 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 2.The Research Group for Population‐based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1992‐1993: estimates based on data from seven population‐based cancer registries . Jpn. J. Clin. Oncol. , 28 , 641 – 647 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 3.Rosa , G. S. , Calogero , C. , Felice , F. , Flavia , P. , Gennaro , D. . and Luigi , P.Hepatocellular carcinoma. A worldwide problem and the major risk factors . Dig. Dis. Sci. , 36 , 962 – 972 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 4.Moore , M. R. , Drinkwater , N. R. , Miller , E. C. , Miller , J. A. . and Pilot , H. C.Quantitative analysis of the time‐dependent development of glucose‐6‐phosphatase‐deficient foci in the livers of mice treated neonatally with diethylnitrosamine . Cancer Res. , 41 , 1585 – 1593 ( 1981. ). [PubMed] [Google Scholar]
  • 5.Vesselinovitch , S. D. , Itze , L. , Mihailovich , N. . and Rao , K. V. N.Modifying role of partial hepactectomy and gonadectomy in ethylnitrosourea‐induced hepatocarcinogenesis . Cancer Res. , 40 , 1538 – 1542 ( 1980. ). [PubMed] [Google Scholar]
  • 6.Vesselinovitch , S. D. , Mihailovich , N. , Rao , K. V. N. . and Goldfarb , S.Relevance of basophilic foci to promoting effect of sex hormones on hepatocarcinogenesis . In “ Carcinogenesis ,” Vol. 7 , ed. Hecker E. , Fusenig N. E. , Kunz W. , Marks F. and Theilmann H. W. , pp . 127 – 131 ( 1982. ). Raven Press; , New York . [PubMed] [Google Scholar]
  • 7.Moser , G. J. , Wolf , D. C. , Wong , B. A. . and Goldsworthy , T. L.Loss of tumor‐promoting activity of unleaded gasoline in N‐nitrosodiethylamine‐initiated ovariectomized B6C3Fj mouse liver . Carcinogenesis , 18 , 1075 – 1083 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 8.Yu , L. , Kubota , H. , Yamaguchi , M. . and Nagasue , N.Heterogeneity in androgen receptor levels and growth response to dihydrotestosterone in sublines derived from human hepatocellular carcinoma line (KYN‐1) . Liver , 17 , 35 – 40 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 9.Yu , L. , Nagasue , N. , Yamaguchi , M. . and Chang , Y.Effects of castration and androgen replacement on tumor growth of human hepatocellular carcinoma in nude mice . J. Hepatol. , 25 , 362 – 369 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 10.Ikeyama , S. , Masaki , T. . and Sudo , K.Antitumor effect of controlled release formulation of leuprorelin acetate (Leuplin) in DMBA (dimethylbenzanthracene)‐induced mammary tumors in rats . Jpn. Pharmacol. Ther. , 22 , 137 – 140 ( 1994. ). [Google Scholar]
  • 11.Ikeyama , S. , Masaki , T. . and Sudo , K.The direct extra‐pituitary actions of controlled release formulation of leuprorelin acetate (Leuplin) . Jpn. Pharmacol. Ther. , 22 , 141 – 146 ( 1994. ). [Google Scholar]
  • 12.Untch , M.Primary endocrine therapy as pre‐ and perimenopausal metastatic breast carcinoma with leuprorelin acetate depot. German Leuprorelin Study Group . Zentralbl. Gynakol. , 120 , 284 – 294 ( 1998. ). [PubMed] [Google Scholar]
  • 13.Jocham , D.Leuprorelin three‐month depot in the treatment of advanced and metastatic prostate cancer: long‐term follow‐up results . Urol. Int. , 60 ( Suppl. 2 ), 18 – 24 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 14.Zerbib , M. , Lucas , C. . and Leblanc , V.Effectiveness and tolerance of three month sustained release leuprorelin in the treatment of metastatic prostatic cancer (comparative, randomized, multicentric study) . Prog. Urol. , 7 , 246 – 253 ( 1997. ). [PubMed] [Google Scholar]
  • 15.Forbes , A. , Wilkinson , M. L. , Iqbal , M. J. , Johnson , P. J. . and Williams , R.Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5 α‐dihydrotestosterone . Eur. J. Cancer Clin. Oncol , 23 , 1659 – 1664 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 16.Nagasue , N. , Kohno , H. , Chang , Y. C. , Hayashi , T. , Utsumi , Y. , Nakamura , T. . and Fukaya , H.Androgen and estrogen receptors in hepatocellular carcinoma and surrounding liver in women . Cancer , 63 , 112 – 116 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 17.Chao , Y. , Chan , W. K. , Huang , Y. S. , Teng , H. C. , Wang , S. S. , Lui , W. Y. , Jacquline , W. P. . and Lee , S. D.Phase II study of flutamide in the treatment of hepatocellular carcinoma . Cancer , 77 , 635 – 639 ( 1996. ). [PubMed] [Google Scholar]
  • 18.Nomura , K. , Ando , T. . and Demura , H.Leuproide acetate prevents toxic effects of cisplatin on the kidneys and gastrointestinal tract . Endocr. J. , 42 , 315 – 321 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 19.DeSombre , E. R. , Johnson , E. S. . and White , W. F.Regression of rat mammary tumors effected by a gonadoliberin analog . Cancer Res. , 36 , 3830 – 3833 ( 1976. ). [PubMed] [Google Scholar]
  • 20.Okada , H. , Sakura , Y. , Kawaji , H. , Yashiki , T. . and Mima , H.Regression of rat mammary tumors by a potent luteinizing hormone releasing hormone (Leuprolide) administered vaginally . Cancer Res. , 43 , 1869 – 1874 ( 1983. ). [PubMed] [Google Scholar]
  • 21.Scott , R. T. , Jr. , Illions , E. H. , Carey , K. D. . and Navot , D.Gonadotropin‐releasing hormone antagonist administration enhances gonadotropin responsiveness at doses inadequate to suppress immunoassayable gonadotropin levels . Fertil. Steril. , 62 , 5 ( 1994. ). [PubMed] [Google Scholar]
  • 22.Eagon , P. K. , Elm , M. S. , Epley , M. J. , Shinozuka , H. . and Rao , K. V. N.Sex steroid metabolism and receptor status in hepatic hyperplasia and cancer in rats . Gastroenterology , 110 , 1199 – 1207 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 23.Kemp , C. J. . and Drinkwater , N. R.Genetic variation in liver tumor susceptibility, plasma testosterone levels, and androgen receptor binding in six inbred strains of mice . Cancer Res. , 49 , 5044 – 5047 ( 1989. ). [PubMed] [Google Scholar]
  • 24.Ward , J. M. . and Vlahakis , G.Evaluation of hepatocellular neoplasm in mice . J. Natl. Cancer Inst. , 61 , 807 – 811 ( 1978. ). [PubMed] [Google Scholar]
  • 25.Vorce , R. L. . and Goodman , J. I.Alterations in the methylation status of ras oncogenes in BCF1 mouse liver tumors . In “ Mouse Liver Carcinogenesis: Mechanisms and Species Comparisons ,” ed. Stevenson D. E. , McClain R. M. , Popp J. A. , Slage T. J. , Ward J. M. and Pilot H. C. , pp . 335 – 343 ( 1990. ). Wiley‐Liss; , New York . [PubMed] [Google Scholar]
  • 26.Lee , G. H. , Nomura , K. , Kanda , H. , Kasukabe , M. , Yoshiki , A. , Sakamura , T. . and Kitagawa , T.Strain specific sensitivity to diethylnitorosamine‐induced carcinogenesis is maintained in hepatocytes of C3H/HeN ↔ C57BL/6N chimeric mice . Cancer Res. , 51 , 3257 – 3260 ( 1991. ). [PubMed] [Google Scholar]
  • 27.Gustafsson , J.‐A. . and Stenberg , A.On the obligatory role of the hypophysis in sexual differentiation of hepatic metabolism in rats . Proc. Natl. Acad. Sci. USA , 73 , 1462 – 1465 ( 1976. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Toh , Y. C.Physiological and biochemical reviews of sex differences and carcinogenesis with particular reference to the liver . Adv. Cancer , 18 , 155 – 209 ( 1973. ). [PubMed] [Google Scholar]
  • 29.Erdstein , J. , Wisebord , S. , Mishkin , S. Y. . and Mishkin , S.The effect of several sex steroid hormones on the growth rate of three Morris hepatoma tumor lines . Hepatology , 9 , 621 – 624 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 30.Reuber , M. D.Importance of testes in induction of hyper‐plastic nodules, carcinomas, and cirrhosis of liver AxC male rats ingesting 0.025% N‐2‐fluorenyldiacetamide . J. Natl. Cancer Inst , 53 , 883 – 886 ( 1974. ). [DOI] [PubMed] [Google Scholar]
  • 31.Goodall , C. M. . and Butler , W. H.Aflatoxin carcinogenesis: inhibition of liver cancer induction in hypophysectomized rats . Int. J. Cancer , 4 , 422 – 429 ( 1969. ). [DOI] [PubMed] [Google Scholar]
  • 32.Friedman , L. . and Yin , L.Influence of hypophysectomy on the biochemical effects and metabolism of aflatoxin B1 in rats . J. Natl. Cancer Inst. , 51 , 479 – 487 ( 1973. ). [PubMed] [Google Scholar]
  • 33.Carr , B. I. . and van Thiel , D. H.Hormonal manipulation of human hepatocellular carcinoma: a clinical investigation and therapeutic opportunity . J. Hepatol. , 11 , 287 – 289 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 34.Wilkinson , M. L. . and Forbes , A.Hormonal treatment of hepatocellular carcinoma . J. Hepatol. , 14 , 406 – 407 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 35.Forbes , A. , Wilkinson , M. L. , Iqbal , M. J. , Johnson , P. J. . and Williams , R.Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5α‐dihydrotestosterone . Eur. J. Cancer Clin. Oncol. , 23 , 1659 – 1664 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 36.Guechot , J. , Peigney , N. , Ballet , F. , Vaubourdolle , M. , Giboudeau , J. . and Poupon , R.Effect of D‐tryptophan‐6‐luteinizing hormone‐releasing hormone on the tumoral growth and plasma sex steroid levels in cirrhotic patients with hepatocellular carcinoma . Hepatology , 10 , 346 – 348 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 37.Gupat , A. . and Korula , J.Failure of ketoconazole as antiandrogen therapy in non‐resectable primary hepatocellular carcinoma . J. Clin. Gastroenterol. , 10 , 651 – 654 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 38.Kemp , C. J. . and Drinkwater , N. R.Genetic variation in liver tumor susceptibility, plasma testosterone levels and androgen receptor binding in six inbred strains of mice . Cancer Res. , 49 , 5044 – 5047 ( 1989. ). [PubMed] [Google Scholar]
  • 39.Kemp , C. J. . and Drinkwater , N. R.The androgen receptor and liver tumor development in mice . In “ Mouse Liver Car‐cinogenesis: Mechanism and Species Comparisons ,” ed. Stevenson D. E. , McClain R. M. , Popp J. A. , Slaga T. J. , Ward J. M. and Pilot H. C. , pp . 230 – 214 ( 1990. ). Wiley‐Liss; , New York . [PubMed] [Google Scholar]
  • 40.Ito , A. , Takahashi , T. , Watanabe , H. , Ogundigie , P. O. . and Okamoto , T.Significance of strain and sex differences in the development of 252Cf neutron‐induced liver tumors in mice . Jpn. J. Cancer Res. , 83 , 1052 – 1056 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Peter , O. , Okamoto , T. , Ando , Y. , Watanabe , H. . and Ito , A.Inhibitory effect of transient administration of flutamide (SCH13521, 4′‐nitro‐3′trifluoromethyl‐isobutyranilide) on diethylnitrosamine (DEN) induced liver tumors in male BeCSF1 mice . Oncol. Rep. , 2 , 123 – 127 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 42.Tenniswood , M. P. , Guenette , R. S. , Lakins , J. , My , K. , Wy , P. . and Welsh , J.‐E.Active cell death in hormone‐dependent tissue . Cancer Metastasis Rev. , 11 , 197 – 220 ( 1992. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES